Nov 1, 2024, 17:10
ESTRO-EANO guideline on target delineation and radiotherapy for grade 2 and 3 diffuse glioma
“ESTRO-EANO guideline on target delineation and radiotherapy for IDH mutant WHO CNS grade 2 and 3 diffuse glioma, just published in the Green Journal.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 17:57
Nov 14, 2024, 17:46
Nov 14, 2024, 17:46
Nov 14, 2024, 17:42
Nov 14, 2024, 17:14